Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Vivani Medical (NASDAQ:VANI) reported quarterly earnings of $0.04 per share. This is a 140 percent increase over losses of $(0.10) per share from the same period last year.
Gainers
OpGen (NASDAQ:OPGN) shares rose 20.6% to $0.52 during Monday's after-market session. This security traded at a volume of 927.4K shares come close, making up 324.6% of its average volume over the last 100 days. The company's market cap stands at $25.0 million.